Inclusion and use of ethical analysis in health technology assessment reports relevant to genomic newborn screening
International Journal of Technology Assessment in Health Care · 2026
DOI: 10.1017/s0266462326104115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Technology Assessment in Health Care, 2026. Verfasst von Siun Gallagher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Australia. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Neonatal Screening, Genetic Testing, Ethical Analysis. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Advances in the use of genomic technologies in newborn bloodspot screening (NBS) raise ethical challenges that should be systematically and critically considered. We examine how ethical analyses have been incorporated into health technology assessments (HTA) relevant to genomic NBS to inform how ethics might be incorporated in Australian HTAs of genomic NBS.
Methods
We conducted an inductive content analysis of publicly available HTA reports and summaries relevant to genomic NBS published between January 2013 and June 2023 across 18 countries. Eligible reports related to genetic or genomic testing or population screening. These reports were screened for inclusion of ethical considerations and coded with NVivo for their presence, structure, and reported influence on decision making. Twelve reports with substantial ethical discussion were examined in-depth through qualitative thematic analysis.
Results
One hundred and ninety reports met our inclusion criteria, with Spain, Australia, and the United Kingdom heavily represented. Ethics was mentioned in 39 percent of reports, and ethical analysis appeared to influence recommendations in 13 percent. When present, ethical considerations focused on equity, harm, and autonomy. Consideration of ethical issues was mostly unstructured, descriptive, and lacked normative conclusions.
Conclusions
Although a range of ethical considerations were raised in the HTA reports relevant to genomic NBS, ethical analyses were generally inconsistently applied or reported, and the way in which ethics has influenced HTA recommendations was not always clear. Further work is needed to understand how the role of ethics in Australian HTAs of genomic NBS could be strengthened to ensure ethically defensible decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Australia.
- Faculty of Medicine and Health, Sydney School of Public Health, The Leeder Centre for Health Policy, Economics and Data, The University of Sydney, Australia.
ORCID-Profile: Joanne Scarfe, Sarah Norris
Zitieren
APA
Gallagher, S., Scarfe, J., Newson, A. J., & Norris, S. (2026). Inclusion and use of ethical analysis in health technology assessment reports relevant to genomic newborn screening. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462326104115
Vancouver
Gallagher S, Scarfe J, Newson AJ, Norris S. Inclusion and use of ethical analysis in health technology assessment reports relevant to genomic newborn screening. International Journal of Technology Assessment in Health Care. 2026. doi:10.1017/s0266462326104115
BibTeX
@article{Gallagher2026,
author = {Gallagher, Siun and Scarfe, Joanne and Newson, Ainsley J and Norris, Sarah},
title = {Inclusion and use of ethical analysis in health technology assessment reports relevant to genomic newborn screening},
journal = {International Journal of Technology Assessment in Health Care},
year = {2026},
doi = {10.1017/s0266462326104115}
}
EUVIMED